Correlation Between Navidea Biopharmaceutica and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navidea Biopharmaceuticals and Elevation Oncology, you can compare the effects of market volatilities on Navidea Biopharmaceutica and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and Elevation Oncology.
Diversification Opportunities for Navidea Biopharmaceutica and Elevation Oncology
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Navidea and Elevation is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and Elevation Oncology go up and down completely randomly.
Pair Corralation between Navidea Biopharmaceutica and Elevation Oncology
Given the investment horizon of 90 days Navidea Biopharmaceuticals is expected to generate 0.96 times more return on investment than Elevation Oncology. However, Navidea Biopharmaceuticals is 1.04 times less risky than Elevation Oncology. It trades about 0.08 of its potential returns per unit of risk. Elevation Oncology is currently generating about 0.01 per unit of risk. If you would invest 9.00 in Navidea Biopharmaceuticals on September 2, 2024 and sell it today you would earn a total of 0.96 from holding Navidea Biopharmaceuticals or generate 10.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 8.06% |
Values | Daily Returns |
Navidea Biopharmaceuticals vs. Elevation Oncology
Performance |
Timeline |
Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Elevation Oncology |
Navidea Biopharmaceutica and Elevation Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Navidea Biopharmaceutica and Elevation Oncology
The main advantage of trading using opposite Navidea Biopharmaceutica and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |